Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

The addition of endothelial cell growth factor and heparin to human umbilical vein endothelial cell cultures decreases plasminogen activator inhibitor-1 expression.
B A Konkle, D Ginsburg
B A Konkle, D Ginsburg
Published August 1, 1988
Citation Information: J Clin Invest. 1988;82(2):579-585. https://doi.org/10.1172/JCI113635.
View: Text | PDF
Research Article

The addition of endothelial cell growth factor and heparin to human umbilical vein endothelial cell cultures decreases plasminogen activator inhibitor-1 expression.

  • Text
  • PDF
Abstract

Plasminogen activator inhibitor-1 (PAI-1) is a specific and rapid inhibitor of tissue plasminogen activator (tPA) and urokinase. Clinical studies suggest that PAI-1 may play a crucial role in the regulation of fibrinolysis. A number of factors modulate PAI-1 activity in endothelial cell culture, and the isolation of PAI-1 cDNA now allows study of PAI-1 regulation at the mRNA level. We examined the effect of endothelial cell growth factor (ECGF) and heparin on PAI-1 expression in human umbilical vein endothelial cell (HUVEC) culture. The addition of ECGF and heparin to HUVEC cultures results in a 3-10-fold decrease in the PAI-1 activity secreted into the conditioned media. This effect is mediated at the mRNA level. A decrease in PAI-1 is also seen with higher concentrations of ECGF alone, but is greatly enhanced by the addition of heparin. No significant change in tPA antigen or mRNA levels was observed.

Authors

B A Konkle, D Ginsburg

×

Total citations by year

Year: 2020 2018 2012 2010 2009 2008 2007 2005 2003 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1989 1988 Total
Citations: 1 1 1 2 1 1 2 1 1 3 1 1 4 3 4 2 4 7 11 10 4 1 66
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (66)

Title and authors Publication Year
Altered Protein Function Caused by AMD-associated Variant rs704 Links Vitronectin to Disease Pathology
F Biasella, K Plössl, C Karl, BH Weber, U Friedrich
Investigative ophthalmology & visual science 2020
Intermittent Hypoxia Activates Duration-Dependent Protective and Injurious Mechanisms in Mouse Lung Endothelial Cells
P Wohlrab, L Soto-Gonzales, T Benesch, MP Winter, IM Lang, K Markstaller, V Tretter, KU Klein
Frontiers in physiology 2018
Angiogenèse: retour au fondamental
PM Martin, LH Ouafik
Oncologie 2012
Relations du système plasminogène-plasmine et cancer
PM Martin, C Dussert, S Romain, LH Ouafik
Oncologie 2010
Stroma : partenaire actif mais sous-estiméde la tumorigenèse, « quand le dialogue remplace le monologue »
PM Martin, C Dussert, LH Ouafik
Oncologie 2010
Respiratory response of malignant and placental cells to changes in oxygen concentration
A Garedew, U Kämmerer, D Singer
Respiratory Physiology & Neurobiology 2009
Akt kinase targets association of CBP with SMAD 3 to regulate TGFbeta-induced expression of plasminogen activator inhibitor-1
F Das, N Ghosh-Choudhury, B Venkatesan, X Li, L Mahimainathan, GG Choudhury
Journal of Cellular Physiology 2008
Unfractionated Heparin but Not Enoxaparin Causes Delayed Plasma PAI-1 Depletion in Hemodialysis Patients: A Prospective Study
B Naumnik, K Pawlak, M Mysliwiec
Clinical and Applied Thrombosis/Hemostasis 2007
Cancer du sein avancé
D Serin, G de Rauglaudre
2007
Modification by the tissue plasminogen activator-plasmin system of morphine-induced dopamine release and hyperlocomotion, but not anti-nociceptive effect in mice
T Nagai, H Kamei, M Ito, K Hashimoto, K Takuma, T Nabeshima, K Yamada
Journal of Neurochemistry 2005
Effect of plasminogen activator inhibitor–1 in diabetes mellitus and cardiovascular disease
CJ Lyon, WA Hsueh
The American Journal of Medicine 2003
Selective Inhibition by α-Tocopherol of Vascular Cell Adhesion Molecule-1 Expression in Human Vascular Endothelial Cells
D Zapolska-Downar, A Zapolski-Downar, M Markiewski, A Ciechanowicz, M Kaczmarczyk, M Naruszewicz
Biochemical and Biophysical Research Communications 2000
Protein kinase C-β mediates lipoprotein-induced generation of PAI-1 from vascular endothelial cells
S Ren, S Shatadal, GX Shen
American journal of physiology. Endocrinology and metabolism 2000
Mechanical stress enhances expression and production of plasminogen activator in aging human periodontal ligament cells
S Miura, M Yamaguchi, N Shimizu, Y Abiko
Mechanisms of Ageing and Development 2000
Evidence that Heparin but Not Hirudin Reduces PAI-1 Expression in Cultured Human Endothelial Cells
J Orbe, R Montes, N Zabalegui, A Pérez-Ruiz, JA Páramo
Thrombosis Research 1999
Alcohol-Induced Upregulation of Plasminogen Activators and Fibrinolytic Activity in Cultured Human Endothelial Cells
ML Aikens, HE Grenett, RL Benza, EM Tabengwa, GC Davis, FM Booyse
Alcoholism, clinical and experimental research 1998
Atherosclerosis
EM MD, ST MD, EA MD, AW MD, ED MD
The Annals of Thoracic Surgery 1997
Oxidative modification enhances lipoprotein(a)-induced overproduction of plasminogen activator inhibitor-1 in cultured vascular endothelial cells
S Ren, RY Man, A Angel, GX Shen
Atherosclerosis 1997
Acidic and Basic Fibroblast Growth Factors Suppress Transcriptional Activation of Tissue Factor and Other Inflammatory Genes in Endothelial Cells
UR Pendurthi, JT Williams, LV Rao
Arteriosclerosis, thrombosis, and vascular biology 1997
Human Endothelial Cells in Culture and In Vivo Express on Their Surface All Four Components of the Glycoprotein Ib/IX/V Complex
G Wu, DW Essex, FJ Meloni, T Takafuta, K Fujimura, BA Konkle, SS Shapiro
Blood 1997
Fibroblast growth factor and heparin protect endothelial cells from the effects of interleukin 1
AJ Minter, E Keoshkerian, CN Chesterman, J Dawes
Journal of Cellular Physiology 1996
Comparison of the effects of unfractionated heparin, low molecular weight heparin and hirudin (revasc™) on the fibrinolytic potential of cultured human umbilical vein endothelial cells
C Chordá, JA Páramo, E Rocha
Fibrinolysis 1996
Molecular Mechanisms of Coronary Collateral Vessel Growth
W Schaper, WD Ito
Circulation research 1996
Shear stress-mediated changes in the expression of leukocyte adhesion receptors on human umbilical vein endothelial cellsin vitro
R Sampath, GL Kukielka, CW Smith, SG Eskin, LV McIntire
Annals of Biomedical Engineering 1995
Inhibition by Modified Oligodeoxynucleotides of the Expression of Type-1 Plasminogen Activator Inhibitor in Human Endothelial Cells
CS Cierniewski, A Babinska, M Swiatkowska, M Wilczynska, A Okruszek, WJ Stec
European Journal of Biochemistry 1995
Acidic and Basic Fibroblast Growth Factors have Comparable Effects on the Haemostatic Function of Vascular Endothelium
AW Ashton, J Dawes, CN Chesterman
Growth Factors 1995
Improving the efficacy and stability of coronary reperfusion following thrombolysis: Exploring the thrombin hypothesis
RC Becker
Journal of Thrombosis and Thrombolysis 1995
Complementary DNA cloning of the alternatively expressed endothelial cell glycoprotein Ib beta (GPIb beta) and localization of the GPIb beta gene to chromosome 22
MD Kelly, DW Essex, SS Shapiro, FJ Meloni, T Druck, K Huebner, BA Konkle
Journal of Clinical Investigation 1994
Modulation of bovine microvascular endothelial cell proteolytic properties by inhibitors of angiogenesis
MS Pepper, JD Vassalli, L Orci, R Montesano, JW Wilks, L Schweigerer
Journal of Cellular Biochemistry 1994
Influence of oral intake of retinoids on the human plasma fibrinolytic system
PJ Declerck, G Boden, H Degreef, D Collen
Fibrinolysis 1993
Augmentation of interleukin-1 induced prostacyclin production by endothelial cell growth factor: Implications for chronic synovitis
G Spencer-Green, KM Caulkins
Prostaglandins 1993
Decreased plasma fibrin degradation products during hormonal stimulation for in vitro fertilisation
M Hanss, MC Trzeciak, J Ninet, C Jurus, D Boulieu, M Dechavanne
Fibrinolysis 1993
Plasminogen activator inhibitor-1 mRNA is expressed in platelets and megakaryocytes and the megakaryoblastic cell line CHRF-288
BA Konkle, PK Schick, X He, RJ Liu, EM Mazur
Arteriosclerosis Thrombosis and Vascular Biology 1993
Functional analysis of a type IIB von Willebrand disease missense mutation: increased binding of large von Willebrand factor multimers to platelets
KA Cooney, SE Lyons, D Ginsburg
Proceedings of the National Academy of Sciences 1992
Induction of t-PA Synthesis with intravenous bolus injection of vitamin A palmitate in vitamin a deficient rats
F Bulens, AE Thompson, JM Stassen, H Moreau, PJ Declerck, L Nelles, D Collen
Fibrinolysis 1992
Characterization and regulation of the urokinase receptor of human endothelial cells
ES Barnathan
Fibrinolysis 1992
Tissue Plasminogen Activator Expression in Endothelial Cells Exposed to Cyclic Strain in Vitro
T Iba, BE Sumpio
Cell Transplantation 1992
Angiogenesis in Health and Disease
ME Maragoudakis, P Gullino, PI Lelkes
1992
Saturation mutagenesis of the plasminogen activator inhibitor-1 reactive center
PM Sherman, DA Lawrence, AY Yang, ET Vandenberg, D Paielli, ST Olson, JD Shore, D Ginsburg
The Journal of biological chemistry 1992
cDNA cloning and molecular characterization of MSE55, a novel human serum constituent protein that displays bone marrow stromal/endothelial cell-specific expression
WF Bahou, AD Campbell, MS Wicha
The Journal of biological chemistry 1992
The molecular defect in type IIB von Willebrand disease. Identification of four potential missense mutations within the putative GpIb binding domain
KA Cooney, WC Nichols, ME Bruck, WF Bahou, AD Shapiro, EJ Bowie, HR Gralnick, D Ginsburg
Journal of Clinical Investigation 1991
Effect of retinoic acid on the synthesis of tissue-type plasminogen activator and plasminogen activator inhibitor-1 in human endothelial cells
EA THOMPSON, L NELLES, D COLLEN
European Journal of Biochemistry 1991
Acidic fibroblast growth factor promotes vascular repair
TD Bjornsson, M Dryjski, J Tluczek, R Mennie, J Ronan, TN Mellin, KA Thomas
Proceedings of the National Academy of Sciences 1991
Potentiation of the activity of mouse liver-derived HBGF-1-like growth factor by heparin and dithiothreitol: evidence for the involvement of a plasma factor
T Nagasaki, MA Lieberman
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1991
Angiostatic cortexone-heparin combination treatment suppresses chronic granulomatous inflammation in mice
CJ Dunn, LA Galinet
Drug Development Research 1991
International Review of Cytology
RA Miller
International Review of Cytology 1991
Regulation of PAI-1 gene expression
DJ Loskutoff
Fibrinolysis 1991
The activation of plasminogen by tissue plasminogen activator is not enhanced by different heparin species as assessed in vitro with a solid-phase fibrin method
P Grailhe, E Anglés-Cano
Fibrinolysis 1991
Cultivation of human dermal microvascular endothelial cells in vitro: Immunocytochemical and ultrastructural characterization and effect of treatment with three synthetic retinoids
E Imcke, Z Ruszczak, AM Silva, M Detmar, CE Orfanos
Archives of Dermatological Research 1991
IL-1-induced procoagulant and fibrinolytic activities of human endothelium grown on carbodiimide crosslinked proteins
R Warocquier-Clrout, J Penhoat, MF Sigot-Luizard
Cytotechnology 1991
Lipoprotein (a) regulates plasminogen activator inhibitor-1 expression in endothelial cells. A potential mechanism in thrombogenesis
OR Etingin, DP Hajjar, KA Hajjar, PC Harpel, RL Nachman
The Journal of biological chemistry 1991
Heparin and acidic fibroblast growth factor interact to decrease prostacyclin synthesis in human endothelial cells by affecting both prostaglandin H synthase and prostacyclin synthase
BB Weksler
Journal of Cellular Physiology 1990
Rapid cellular luminal coverage of Dacron inferior vena cava prostheses in dogs by immediate seeding of autogenous endothelial cells derived from omental tissue: Results of a preliminary trial
Z Wang, W Du, G Li, L Pu, JB Sharefkin
Journal of Vascular Surgery 1990
Plasminogen activator inhibitors: hormonally regulated serpins
PA Andreasen, B Georg, LR Lund, A Riccio, SN Stacey
Molecular and Cellular Endocrinology 1990
Enhanced thrombolytic efficacy and reduction of infarct size by simultaneous infusion of streptokinase and heparin
G Melandri, A Branzi, F Semprini, V Cervi, N Galiè, B Magnani
British heart journal 1990
Modulation of Ca2+-dependent intercellular adhesion in bovine aortic and human umbilical vein endothelial cells by heparin-binding growth factors
LM Bavisotto, SM Schwartz, RL Heimark
Journal of Cellular Physiology 1990
Tissue plasminogen activator messenger RNA levels increase in cultured human endothelial cells exposed to laminar shear stress
SL Diamond, JB Sharefkin, C Dieffenbach, K Frasier-Scott, LV McIntire, SG Eskin
Journal of Cellular Physiology 1990
Annotation DOES HEPARIN STIMULATE FIBRINOLYSIS?
N Marsh
British Journal of Haematology 1990
New Trends in Haemostasis
J Harenberg, DL Heene, G Stehle, G Schettler
1990
Cytokine-enhanced expression of glycoprotein Ib alpha in human endothelium
BA Konkle, SS Shapiro, AS Asch, RL Nachman
The Journal of biological chemistry 1990
Heparin-binding growth factor-1 modulation of plasminogen activator inhibitor-1 expression. Interaction with cAMP and protein kinase C-mediated pathways
BA Konkle, PR Kollros, MD Kelly
The Journal of biological chemistry 1990
Cytokines as communication signals between leukocytes and endothelial cells
A Mantovani, E Dejana
Immunology Today 1989
Heparin stimulation of plasminogen activator secretion by macrophage-like cell line raw264.7: Role of the scavenger receptor
DJ Falcone
Journal of Cellular Physiology 1989
Structure and expression of the human gene encoding plasminogen activator inhibitor, PAI-1
M Follo, D Ginsburg
Gene 1989
Decreased prostacyclin production by human umbilical vein endothelial cells cultured with endothelial cell growth factor and heparin
O Boutherin-Falson, N Blaes
Thrombosis Research 1989
International Review of Experimental Pathology
P Hoedemaeker
International Review of Experimental Pathology 1988

← Previous 1 2 3 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts